Clasado Biosciences are shaping the future of public health
Entrepreneurs create companies that better the world and strengthen economies. E2E’s mission is for our ecosystem to be the beating heart that makes it happen. Our E2E Ambassadors positively impact the lives of millions each day and we are proud of the community we are building.
Per Rehné is the CEO at Clasado Biosciences and E2E Ambassador. Clasado is a leading innovator in the field of galactooligosaccharide (GOS) technology, delivering clinically proven prebiotic solutions to improve human health. We asked Per, what inspired him to become an entrepreneur and what’s next for Clasado Biosciences.
Here is what he shared with us:
”What inspired me from the start, and continues to drive me forwards, is the potential to create true global health change through our operations, as well as the opportunity to create an optimal team with a shared goal and vision.
At Clasado Biosciences, we increase the global reach of prebiotics through the development and geographic expansion of Bimuno GOS, the most studied ingredient of its kind. It’s no secret that gut health has been climbing the consumer health agenda and is gathering momentum, so how to keep moving the prebiotic category forward has a great deal of importance.
The mission that drives Clasado Biosciences forward is to leverage our class-leading portfolio of gut microbiome science, support speed to market and value to our health and nutrition customers and create a diverse and welcoming company culture that encourages everyone to excel. By keeping our mission front of mind at all times, we will remain the gold standard in functional ingredient technology.”
Clasado Biosciences (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has shared its perspective on the growing role of prebiotics in supporting better overall public health.
The business, which develops and manufactures the multi-award-winning Bimuno® GOS prebiotic ingredient, believes that as the global drive for better health solutions accelerates, prebiotic fibre has a central role to play in making it a reality.
Per Rehné, CEO at Clasado, explains: “With the global health audience, we’re getting a fuller and more complete picture of public health challenges and where the key focus areas will be in the future. With each new study, it is becoming ever clearer that prebiotics have a key role to play in safeguarding public health.
“It’s no secret that the Covid-19 pandemic has put renewed focus on immune health. The body’s natural ability to fight off disease and illness has become a key point of focus, and of course, changing work habits and lockdowns have driven greater mental health awareness. These are key areas of study in the prebiotic realm and some of prebiotic fibre’s key strengths. As the market continues its relentless drive towards better everyday health and simpler solutions, we are set to see prebiotic not just strengthen its foothold, but in many cases dominate the public health conversation.”
As it continues to expand into new global health markets, Clasado Biosciences aims to make health simpler by accelerating the highly promising – and relatively new – category of prebiotics. The business notes the well-known fibre gap as one of the key driving forces in the rising demand for functional fibres.
Per continues: “We are seeing extremely rapid growth in the prebiotic category as formulators look to strengthen nutritional profiles and launch new health supplements, but there are even wider implications for improving public health in a more holistic way.
“Studies on behalf of Public Health England found that just 9% of adults are reaching their recommended daily intake of fibre and this problem is mirrored around the globe. With all the established and emerging benefits of fibre – and prebiotics in particular – it’s safe to say that prebiotic fibre and its contemporary application is signposting the future of public health. It’s a way we can create true dietary and behavioural change rather than simple stop-start bursts.”
To find out more about Clasado Biosciences, please visit www.clasado.com
Join us as an E2E Ambassador and connect with industry-leading experts, investors and like-minded entrepreneurs.